Evidence map›Paper›PMID 32130182›Full record

ArticleJMIR research protocols2020

A Smartphone App for Self-Monitoring of Rheumatoid Arthritis Disease Activity to Assist Patient-Initiated Care: Protocol for a Randomized Controlled Trial.

Bart F Seppen, Merel J L'ami, Sharon Duarte Dos Santos Rico, Marieke M Ter Wee, Franktien Turkstra, Leo D Roorda, Fabio S Catarinella, Dirkjan van Schaardenburg, Michael T Nurmohamed, Maarten Boers and 1 more

Open access · goldAbstract read
In one paragraph

Article in JMIR research protocols, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
6.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Bart F SeppenAmsterdam Rheumatology and Immunology Center, Reade, Amsterdam, Netherlands.ORCID https://orcid.org/0000-0002-0421-0553
Merel J L'amiAmsterdam Rheumatology and Immunology Center, Reade, Amsterdam, Netherlands.ORCID https://orcid.org/0000-0001-9584-1088
Sharon Duarte Dos Santos RicoAmsterdam Rheumatology and Immunology Center, Reade, Amsterdam, Netherlands.ORCID https://orcid.org/0000-0003-3225-8594
Marieke M Ter WeeDepartment of Epidemiology & Biostatistics, Amsterdam Public Health, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands.ORCID https://orcid.org/0000-0003-3670-4256
Franktien TurkstraAmsterdam Rheumatology and Immunology Center, Reade, Amsterdam, Netherlands.ORCID https://orcid.org/0000-0002-8055-9036
Leo D RoordaDepartment of Rehabilitation, Reade, Amsterdam, Netherlands.ORCID https://orcid.org/0000-0001-9348-5390
Fabio S CatarinellaBrightfish BV, Amsterdam, Netherlands.ORCID https://orcid.org/0000-0003-0761-4956
Dirkjan van SchaardenburgAmsterdam Rheumatology and Immunology Center, Reade, Amsterdam, Netherlands.ORCID https://orcid.org/0000-0003-4006-3762
Michael T NurmohamedAmsterdam Rheumatology and Immunology Center, Reade, Amsterdam, Netherlands.ORCID https://orcid.org/0000-0002-6274-1934
Maarten BoersAmsterdam Rheumatology and Immunology Center, Reade, Amsterdam, Netherlands.ORCID https://orcid.org/0000-0002-6969-283X
Wouter H BosAmsterdam Rheumatology and Immunology Center, Reade, Amsterdam, Netherlands.ORCID https://orcid.org/0000-0003-3720-793X
Reade · NLAmsterdam University Medical Centers · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTelemedicine based on self-measurement of disease activity could be one of the key components to create the health care system of the future. Previous publications in various medical fields have shown that it is possible to safely telemonitor patients while reducing the number of outpatient clinic visits. For this purpose, we developed a mobile phone app for patients with rheumatoid arthritis (RA), which allows them to self-monitor their disease.

objectiveThe objective of this study is to assess the safety and efficacy of self-initiated care assisted by a smartphone app in patients with RA.

methodsThis is a randomized controlled trial that will be performed for 1 year. A total of 176 patients with RA will be randomized to either self-initiated care with only one scheduled follow-up consultation assisted by our app or usual care. The coprimary outcome measures are the number of outpatient clinic consultations with a rheumatologist taking place during the trial period and the mean disease activity score as measured by the disease activity score 28 (DAS28) at 12 months. The secondary outcomes are patient satisfaction, adherence, patient empowerment, and cost evaluation of health care assisted by the app.

resultsRecruitment started in May 2019, and up to 18 months will be required for completion of recruitment. Thus far, 78 patients have been randomized, and thus far, experiences with the app have been positive. The study results are expected to be published by the end of 2021.

conclusionsThe completion of this study will provide important data regarding the following: (1) safety of self-initiated care supported by a smartphone app in terms of DAS28 and (2) efficacy of lowering health care usage with this new strategy of providing health care.

trial registrationNetherlands Trial Register NL7715; https://www.trialregister.nl/trial/7715. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/15105.

Indexed as

rheumatoid arthritissmartphone apptelemonitoring

Identifiers

PMID32130182
PMCPMC7057822
OpenAlexW2992816235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.